![US stocks muted; uncertainty over Fed's rate cutting plans](https://i-invdn-com.investing.com/news/moved_small-LYNXNPEK320P8_L.jpg)
Please try another search
Verde Science, Inc. is a pharmaceutical research and development company. The Company is engaged in medical science consulting business. The Company is focused on the discovery of drugs and treatment modalities, as well as diagnostic devices and pharmaceutical delivery systems for the treatment of diseases and medical issues. The Company is focused on developing medicinal formulations from cannabinoids and tetrahydrocannabinol (THC) compounds for the treatment of various issues, such as migraines, glaucoma, loss of appetite from cancer therapies, and other medical issues. The Company is focused on launching its THC Pharmaceutical Development Program by executing a research program, which involves developing formulations preparing protocols for clinical trials.
Name | Age | Since | Title |
---|---|---|---|
Craig S. Alford | 58 | 2013 | Independent Director |
Lewis Pittman | - | 2014 | Head of Technical Advisory Board |
Thomas O' Brien | - | 2014 | Member of Technical Advisory Board |
Harpreet Singh Sangha | 57 | 2012 | Chairman, CEO, President, CFO, Secretary & Treasurer |
Paul Pelosi | 52 | 2014 | Member of Advisory Board |
Vincent Ramirez | 66 | 2013 | Member of Advisory Board |
Jere Jay | - | 2014 | Member of Technical Advisory Board |
Heiko Mueller | - | 2014 | Member of Technical Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review